Aura Biosciences, Inc. (AURA)
5.60
-0.10
(-1.75%)
USD |
NASDAQ |
Mar 06, 16:00
5.60
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Free Cash Flow : -88.80M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | 13.33M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.14M |
| Cash from Investing (Quarterly) | -44.02M |
| Cash from Financing (Quarterly) | 4.363M |
| Free Cash Flow Per Share (Quarterly) | -0.3062 |
| Free Cash Flow to Equity (Quarterly) | -19.83M |
| Free Cash Flow to Firm (Quarterly) | -20.19M |
| Free Cash Flow Yield | -28.32% |